4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016095
President and CEO gave up 42,724 shares (to pay taxes)
- President and CEO acquired 148,714 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-03-02 | Option exercise | +96,150 | 1,025,053 | D | ||
| Walker Neal President and CEO | 2020-03-02 | Shares withheld for taxes | −27,623 | $1.26 | $34,805 | 997,430 | D |
| Walker Neal President and CEO | 2020-03-02 | Option exercise | +52,564 | 1,049,994 | D | ||
| Walker Neal President and CEO | 2020-03-02 | Shares withheld for taxes | −15,101 | $1.26 | $19,027 | 1,034,893 | D |
| Derivatives | |||||||
| Walker Neal President and CEO | 2020-03-02 | Option exercise · Restricted stock units | −96,150 | 288,450 | D | ||
| Walker Neal President and CEO | 2020-03-02 | Grant or award · Employee Stock Option (Right to Buy) | +255,552 | 255,552 | D | ||
| Walker Neal President and CEO | 2020-03-02 | Grant or award · Restricted stock units | +146,029 | 146,029 | D | ||
| Walker Neal President and CEO | 2020-03-02 | Grant or award · Restricted stock units | +73,015 | 73,015 | D | ||
| Walker Neal President and CEO | 2020-03-02 | Grant or award · Restricted stock units | +52,564 | 52,564 | D | ||
| Walker Neal President and CEO | 2020-03-02 | Option exercise · Restricted stock units | −52,564 | 0 | D | ||
Loading xslF345X03/doc4.xml…